100 related articles for article (PubMed ID: 24750685)
1. Aplastic anemia: possible associations with lymphoproliferative neoplasms.
Tzankov A; Medinger M
Int J Lab Hematol; 2014 Jun; 36(3):382-7. PubMed ID: 24750685
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia.
Go RS; Tefferi A; Li CY; Lust JA; Phyliky RL
Blood; 2000 Nov; 96(10):3644-6. PubMed ID: 11071666
[TBL] [Abstract][Full Text] [Related]
3. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.
Dorr V; Doolittle G; Woodroof J
Am J Hematol; 1996 Jun; 52(2):108-13. PubMed ID: 8638630
[TBL] [Abstract][Full Text] [Related]
4. Aplastic anemia in association with a lymphoproliferative neoplasm: coincidence or causality?
Medinger M; Buser A; Stern M; Heim D; Halter J; Rovo A; Tzankov A; Tichelli A; Passweg J
Leuk Res; 2012 Feb; 36(2):250-1. PubMed ID: 21962338
[No Abstract] [Full Text] [Related]
5. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
6. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
8. Acquired immune mediated aplastic anemia: is it antineoplastic?
Nissen C; Stern M
Autoimmun Rev; 2009 Sep; 9(1):11-6. PubMed ID: 19245859
[TBL] [Abstract][Full Text] [Related]
9. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
10. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Deeg HJ; Storb R
Transplant Sci; 1994 Sep; 4(1):33-41. PubMed ID: 7804695
[TBL] [Abstract][Full Text] [Related]
11. Immunodeficiency-associated lymphoproliferative disorders.
Knowles DM
Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
[TBL] [Abstract][Full Text] [Related]
12. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
13. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies.
García-Suárez J; de Miguel D; Krsnik I; Bañas H; Arribas I; Burgaleta C
Am J Hematol; 2005 Dec; 80(4):271-81. PubMed ID: 16315252
[TBL] [Abstract][Full Text] [Related]
14. A hospital-based case control study of aplastic anemia in Shanghai, China.
Gross SA; Irons RD; Schnatter AR; Ryder J; Wang XQ; Copley GB; Armstrong TW
Chem Biol Interact; 2010 Mar; 184(1-2):165-73. PubMed ID: 20026322
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes.
Saitoh T; Matsushima T; Yamane A; Sakuraya M; Irisawa H; Yokohama A; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
Acta Haematol; 2007; 117(4):238-41. PubMed ID: 17317950
[TBL] [Abstract][Full Text] [Related]
16. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita.
Bohn OL; Whitten J; Spitzer B; Kobos R; Prockop S; Boulad F; Arcila M; Wang L; Teruya-Feldstein J
Int J Surg Pathol; 2013 Oct; 21(5):520-5. PubMed ID: 23222806
[TBL] [Abstract][Full Text] [Related]
18. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.
Itterbeek P; Vandenberghe P; Nevens F; Fevery J; Aerts R; Yap SH; Demuynck H; Fourneau I; Koshiba T; Emonds MP; Roskams T; Boogaerts M; Pirenne J
Transpl Int; 2002 Mar; 15(2-3):117-23. PubMed ID: 11935168
[TBL] [Abstract][Full Text] [Related]
19. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J
Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative lung disorders: a radiologic-pathologic overview. Part II: Neoplastic disorders.
Restrepo CS; Carrillo J; Rosado de Christenson M; Ojeda Leon P; Lucia Rivera A; Koss MN
Semin Ultrasound CT MR; 2013 Dec; 34(6):535-49. PubMed ID: 24332205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
